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Abstract
At birth, the immune system is still in development making neonates more susceptible to infections. The
recognition of microbial ligands is a key step in the initiation of immune responses. It can be mimicked to
stimulate the immune system by the use of synthetic ligands recognising pattern recognition receptors. In human
and mouse, it has been found that neonatal cytokine responses to toll-like receptor (TLR) ligands differ in many
ways from those of adults but the relevant studies have been limited to cord blood and spleen cells. In this study,
we compared the responses in neonate and adult sheep to CpG oligodeoxynucleotides (ODN), a TLR9 ligand, in
both a mucosal and a systemic organ. We observed that in response to CpG-ODN more IL-12 was produced by
neonatal than adult sheep cells from mesenteric lymph nodes (MLN) and spleen. This higher IL-12 response was
limited to the first 20 days after birth for MLN cells but persisted for a longer period for spleen cells. The major IL-
12-producing cells were identified as CD14
+CD11b
+. These cells were poor producers of IL-12 in response to direct
stimulation with CpG-ODN and required the cooperation of other MLN cells. The difference in response to CpG-
ODN between neonates and adults can be attributed to both a higher proportion of CD14
+CD11b
+ cells in
neonate lambs and their higher capacity to produce IL-15. The IL-15 increases IL-12 production by an amplifying
feedback loop involving CD40.
Introduction
Immune responses in neonates differ from those in
adults due to differences in the relative proportions,
phenotypes and functional properties of their immune
cells [1-4]. In infant and neonate mouse a Th2 bias
has been reported that leads to a reduced capacity to
respond efficiently to vaccines that rely on a Th1
immune response for their efficacy. Immunoprophylac-
tic strategies have therefore to be adapted for neonates
and properly targeted. Pattern recognition receptors
are expressed by cells of the innate immune system
and identify microbial components or cellular stress.
Toll-like receptors (TLR) belong to this family of
receptors, and are attractive targets for immunostimu-
lation strategies; consequently, many synthetic mole-
cules that mimic bacterial or viral components have
been generated. Synthetic CpG oligodeoxynucleotides
(CpG-ODN) resembling bacterial DNA have been
extensively used to promote Th1 immune responses
[5] and to control both systemic and mucosal infec-
tions. We observed that a single administration of
CpG-ODN to neonate mice can greatly reduce infec-
tion by Cryptosporidium parvum [6] by inducing the
production IFNg, a cytokine central to the control of
this zoonotic parasite infecting intestinal epithelial cells
[7,8]. CpG-ODN have also been shown to be safe to
use in veterinary species, [9,10] and effective in rumi-
nants for controlling bacterial [11,12], parasitic [13]
and viral infections [14]. The potential of CpG-ODN
for stimulating innate immune responses has been also
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et al. reporting that their administration can reduce
viral shedding of bovine herpes virus-1 [15].
The specificities of the responses of human and
mouse neonatal cells have been described. However,
the relevant studies were limited to human cord blood
cells and mouse spleen cells. Neonate small ruminants,
being much bigger than rodent animal models, allow
the recovery of large numbers of cells from various tis-
sues facilitating investigations. In addition, data
obtained in human or mouse cannot be directly extra-
polated to veterinary species despite the conservation
of TLR throughout evolution. This is because TLR
responses to their agonists may differ between species
due to differential expression among immune cell
populations or differences in binding or signalling
[16-18]. Exploiting the advantages of a large animal
model, the goats, we previously investigated the cyto-
kine response to various TLR ligands of cells isolated
from neonatal and adult lymph nodes draining the
intestine. The intestine is subjected to many changes
after birth due to exposure to dietary antigens and
colonization by the commensal flora. In response to
TLR stimulation, neonate mesenteric lymph nodes
(MLN) cells presented a stronger IFNg and IL-12
response than their adult counterparts [19]. Although
CD8
+ lymphocytes were identified as being responsible
for the IFNg production, the precise nature of the cells
secreting IL-12 was not identified.
Using lambs as a model, we describe further investiga-
tions regarding the age-related differences of cytokine
responses to TLR ligands. In particular, we aimed to
determine until what age neonate MLN and spleen cells
continued to produce more IL-12 than their adult coun-
terparts in response to CpG-ODN stimulation and the
reasons for the difference.
Materials and methods
Animals and cell isolation
The Préalpes adult sheep (aged 6 ± 1 year), neonates
(aged 6 to 14 days) and lambs (aged 20 days) used
were reared in conventional but protected sanitary
facilities (PFIE, INRA, F-37380 Nouzilly, France). New-
born lambs were not separated from their mothers
until one day after birth, to allow them to suckle
colostrum. They were then fed ad libitum with recon-
stituted milk. Experimental protocols were designed in
compliance with French law (Décret 2001-464 29/05/
01) and EEC regulations (86/609/CEE) concerning the
care and use of laboratory animals. Euthanasia was
performed after electric stunning according to AMVA
guidelines (2007) on euthanasia. Cells from freshly
removed MLN or spleen were isolated as previously
described [19].
Reagents
CpG-2006 5’TCGTCGTTTTGTCGTTTTGTCGTT3’
and control-CpG-2006 (Ctl-ODN) 5’TGCTGCTTT-
TGTGCTTTTGTGCTT3’ have a phosphorothioate
backbone and were purchased from Sigma-Aldrich
(Lyon, France). Recombinant human TGFb1 and recom-
binant type I interferons (IFN) (IFNa hybrid, con-
structed with human IFN aAa n daDi sa c t i v ei na l l
mammalian species) were obtained from AbD Serotec
(Oxford, UK). Recombinant human IL-15 was from
Immunotools (Friesoythe, Germany). Recombinant ovine
IL-12 and IL-10 were kindly provided by S. Wattegedera
(Moredun Research Institute, Edinburgh, UK). Anti-
CD40 mAb supernatant clone ILA156 originally pro-
duced by J. Naessens (ILRAD, Nairobi, Kenya) was pro-
vided by I. Schwartz-Cornil.
CpG-ODN stimulation and cytokine quantification by
ELISA and by bioassay
Mesenteric lymph node (MLN) or spleen cells were
stimulated for 48 h, at a density of 1.5 × 10
6/mL in com-
plete RPMI 1640 medium (Gibco-Invitrogen, Cergy-Pon-
toise, France) supplemented with 10% FCS, 100 IU/mL
penicillin, 100 μg/mL streptomycin sulphate and 50 μM
b-mercaptoethanol (Merck Chemicals Ltd., Nottingham,
UK) with Ctl-ODN (1 μM) or CpG-2006 (1 μM). In the
IL-12 neutralisation assay, mouse anti-bovine IL-12
(clone CC301, Serotec) or its isotype control (mouse
IgG2a, Caltag-Invitrogen) was added, at a concentration
of 10 μg/mL, at the same time as the TLR agonist.
In some experiments, rhTGFb1, rovIL-10, rh type I
I F No rr h I L - 1 5w a sa d d e dt oM L Nc e l l sa tt h es a m e
time as Ctl-ODN or CpG-2006. Culture supernatants
were harvested and stored at -20°C until assayed for the
detection of cytokines by ELISA. Intracellular staining
for IL-12 (clone CC301, AbD Serotec) was performed
on MLN cells cultured in complete RPMI medium with
Ctl-ODN or CpG-2006 for 25 h. Brefeldin A (Sigma)
was added to the cells at a concentration of 5 μg/mL,
for the last 5 h of culture.
Pairs of antibodies against bovine cytokines were
obtained from AbD Serotec; these antibodies have been
shown to recognise ovine IL-12 [20,21], IFNg [21] and
I L - 1 0[ 2 0 , 2 2 ] .E L I S Aw a sc a r r i e do u ta sp r e v i o u s l y
described [19]. Incubations were performed at 37°C for
I L - 1 0E L I S Aa n da tr o o mt e m p e r a t u r ef o rt h eo t h e r
ELISA. To assess biologically active TGFb1s e c r e t i o nb y
ovine cells, we used the TGFb1E m a x
® ImmunoAssay
System (Promega, Charbonnières-les-Bains, France)
according to the manufacturer’s instructions.
Type I IFN in cell supernatants were quantified using
a cytopathic effect reduction assay with Madin-Darby
bovine kidney cells challenged with vesicular stomatitis
virus. An internal recombinant IFNa reference was
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was tested over eight serial dilutions. Results are
expressed as type I IFN units per mL.
Colistin treatment and Gram negative bacterial
enumeration
Control and colistin-treated animals were separated
from their mothers directly after birth and bottle-fed
every 12 h for the first day with preheated ewe colos-
trum containing or not containing 50 000 IU/kg body
weight of colistin (Virbac, Carros, France). Thereafter,
they were fed daily ad libitum with reconstituted milk
containing or not containing 100 000 IU/kg body weight
of colistin (Virbac) until the age of 20 days. Mean body
weights were used to prepare the milk containing colis-
tin: 3 kg for 2- to 8-day-old, 4 kg for 9- to 14-day-old
and 7 kg for 15- to 20-day-old lambs. Lambs were
slaughtered at age 20 days and both MLN (for in vitro
cell stimulation as previously described) and distal ileum
contents were collected. To determine the total number
of Gram -ve bacteria, serial dilutions of ileal content
homogenised in PBS were plated onto Drigalski lactose
agar (selective medium for the isolation of Gram -ve
bacteria). The plates were incubated overnight at 37°C
and colonies counted.
Cell sorting and flow cytometry
A high-speed MoFlo cell sorter (Dako, Trappes, France)
was used to sort freshly isolated total MLN cells. In
these experiments, cells were labelled with a mouse anti-
body specific for ovine CD14 (clone CAM36A, VMRD,
Pullman, USA) and stained with a fluorochrome-
conjugated goat anti-mouse immunoglobulin antibody
(Caltag-Invitrogen). Lymph granulocytes in sheep
display intermediate levelso fC D 1 4e x p r e s s i o n[ 2 4 ] .
CD14
+ cell sorting was therefore always performed after
gating on non-granulocytic MLN cells according to SSC/
FSC analysis, although most granulocytes were removed
on the Histopaque gradient. Both CD14
+ and CD14
- cell
fractions were cultured in vitro, with Ctl-ODN or CpG-
2006, or were directly analysed by qRT-PCR.
For intracellular staining of IL-12, stimulated cells were
cultured in the presence of Brefeldin A for the last 5 h.
First, the following purified monoclonal antibodies direc-
ted against ovine markers were used for surface staining:
CD11b (clone MM12A, VMRD), CD14 (clone CAM36A,
VMRD), MHC class II (clone 28.1, AbD Serotec) and
CD205 (clone CC98, AbD Serotec). Fixed and permeabi-
lised cells were then incubated with the mouse anti-
bovine/ovine IL-12 antibody (clone CC301, AbD Serotec).
Electron microscopy
Sorted CD14
+ cells were fixed, post-fixed, dehydrated in
a graded series of ethanol solutions and embedded in
Epon resin (Sigma). Ultrathin sections were cut, stained
and examined under a Jeol 1010 transmission electron
microscope (Jeol, Croissy-sur-Seine, France).
RNA isolation and real-time RT-PCR
RNA was extracted with the NucleoSpin RNA II kit
(Macherey-Nagel, Hoerdt, France), according to the
manufacturer’s instructions and quantified using Nano-
drop (Thermo Fisher Scientific, Courtaboeuf, France).
Purified RNA was reverse-transcribed using oligo(dT)
primers and M-MLV reverse transcriptase (Promega).
Primer pairs were designed using Primer 3 software
(Additional file 1, Table S1). Each primer was designed
on different exons to span the intervening intron and
thus avoid amplification from contaminating genomic
DNA. For each primer pair, all qPCR displayed an effi-
ciency of between 90% and 110%. Diluted cDNA was
combined with primers and IQ SYBRGreen Supermix
(Bio-Rad, Hercules, USA) according to the manufac-
turer’s recommendations and real-time assays were run
on a Bio-Rad Chromo 4 (Bio-Rad). The specificity of the
qPCR reactions was assessed by analysing the melting
curves of the products and size verification of the ampli-
cons. To minimise sample variations, we used identical
numbers of cells and high quality RNA. Hypoxanthine
phosphoribosyltransferase (HPRT) mRNA levels were
used to normalise RNA quantification.
Statistical analyses
Non-parametric Mann-Whitney (two groups) and Krus-
kal-Wallis (three or more groups) statistical tests were
used to compare unpaired values. In case of paired
values, paired t-tests were performed.
Results
IL-12 and IFNg responses of neonatal and adult MLN cells
to CpG-ODN stimulation
Neonatal MLN cells stimulated in vitro with CpG-2006
produced variable but significantly larger amounts of IL-
12 (Figure 1A) and IFNg (Figure 1B) than adult MLN
cells. This higher IL-12 response was also observed for
neonatal spleen cells (Figure 1C). Adult MLN and
spleen effector cells (T cells and NK cells) were not
intrinsically impaired for IFNg production compared to
neonatal cells, as they produced significantly larger
amounts of this cytokine in response to non-specific sti-
mulation in vitro with phorbol myristate acetate asso-
ciated with ionomycin (data not shown). Neutralisation
of IL-12 in vitro indicated that the higher production of
IFNg by neonatal MLN cells was due in large part to
the higher level of IL-12 released upon CpG-2006 sti-
mulation (Figure 1D, 78 ± 12% inhibition, p < 0.005).
We therefore investigated the particular features of the
neonatal cells producing IL-12 in response to CpG-2006.
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to CpG-ODN stimulation
We first studied the evolution with age of the stronger
response in vitro of neonatal cells. We measured IL-12
secretion by MLN and spleen cells from 20-day-old
lambs, neonates and adults. IL-12 secretion by MLN
cells in response to in vitro CpG-2006 stimulation
rapidly decreased with age: cells from 20-day-old lambs
producing as little IL-12 as adult cells (Figure 2A). By
contrast, splenocytes from 20-day-old animals, like neo-
natal cells, secreted significantly larger, albeit variable,
amounts of IL-12 than adult cells (Figure 2B). Thus, the
higher IL-12 response began to decline earlier in MLN
cells than in spleen cells, suggesting major changes in
TLR responsiveness in the lymph nodes within the first
few days of life.
Effect of Gram negative intestinal flora on the response
of neonatal MLN cells to CpG-ODN
The decrease of IL-12 secretion between 14 and 20 days
after birth could be related to progressive installation of
the intestinal microflora. Gram -ve commensal bacteria
have a large impact on the formation of intestinal lym-
phoid tissues and the establishment of gut homeostasis in
mice [25]. To assess the possible role of Gram -ve bacteria
colonisation in our model, lambs were fed with milk sup-
plemented with the antibiotic colistin from birth to
20 days of age. The Gram -ve bacterial count in the distal
ileal content of these animals was at least 4 log lower than
in controls (Figure 3A) but IL-12 response to CpG-2006
was not significantly different (Figure 3B). This suggests
that another mechanism was responsible for the higher
IL-12 secretion by neonatal MLN cells upon TLR ligation.
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Figure 1 Comparative IL-12 and IFNg responses of neonatal and adult cells following TLR agonist stimulation. Neonatal and adult MLN
(A, B) and spleen cells (C) were cultured in vitro with 1 μM Ctl-ODN or 1 μM CpG-2006. Supernatants were harvested after 48 h of culture and
ELISA was carried out for IL-12 (A, C) and IFNg (B) secretions. (D) Mouse anti-bovine IL-12 (grey bar) or its isotype control (hatched bar) was
added to neonatal MLN cells, at the same time as CpG-2006 or Ctl-ODN. IFNg secreted into the culture supernatants was determined after 48 h.
The mean ± SEM concentration of IFNg secretion is shown (CpG-2006 - Ctl-ODN). * p ≤ 0.005; ** p ≤ 0.001.
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Page 4 of 12IL-12-producing cells among lamb bulk MLN cells
We aimed to identify the major IL-12 secreting cell
population to characterise more precisely the mechan-
isms governing the differences between neonates and
adults. ELISA kinetic assays showed that IL-12 secretion
started between 6 and 20 h following CpG stimulation
and that the secretion doubled between 20 h and 28 h
post-stimulation (Figure 4A). We stained neonatal MLN
cells for intracellular IL-12 at 20 h post-stimulation. The
bar graph (Figure 4B) displays the percentage of IL-12
secreting cells among CD11b, CD14, MHC class II and
CD205 positive cells. CD14
+ cells but also CD11b
+ cells
were major contributors to IL-12 secretion in response
to CpG. Flow cytometry anal y s i ss h o w e dt h a tm o s to f
the CD14
+ cells co-expressed CD11b. Moreover, all
CD11b
+ cells co-expressed CD14 (data not shown). We
therefore decided to focus our study on CD14
+ cells.
Transmission electron microscopy revealed that neona-
tal CD14
+ MLN cells had numerous processes and
horseshoe-shaped nuclei, as expected for cells of the
myeloid lineage (Figure 4C). We also observed several
dark electron-dense granules and a well developed endo-
somal compartment resembling that of ovine monocyte-
derived dendritic cells (DC) [26] and a CD11b
int/high
subpopulation of bone marrow-derived DC [27].
CD14
+ and CD14
- cells purified by flow cell sorting
from neonate and adult MLN were stimulated with
CpG-2006. The absence of CD14
+ cells inhibited greatly
IL-12 secretion not only in neonate (67 ± 7%) but also
in adult (85 ± 8%) samples, indicating the essential role
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Figure 2 Age-dependent IL-12 responses. MLN and spleen cells from 6- to 14-day-old neonates (closed circles), 20-day-old lambs (closed
diamonds) and adults (open squares) were cultured in vitro for 48 h, with 1 μM CpG-2006 or 1 μM Ctl-ODN. At the end of the culture period,
supernatants were harvested and ELISA carried out to assay IL-12 secreted by MLN cells (A) or spleen cells (B). Medians are shown for each
stimulus. * p ≤ 0.01; ** p ≤ 0.001; *** p ≤ 0.0005.
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Figure 3 Effect of antibiotic treatment of lambs on the IL-12
response of MLN cells to CpG-2006. Lambs were treated daily for
the first 20 days of life with colistin (closed diamonds) or not
treated (closed triangles). Gram -ve colony counts per mL of distal
ileum content from the two groups were calculated as described in
the methods (A) and IL-12 secretion of MLN cells in response to
CpG-2006 (CpG-2006 - Ctl-ODN) was determined after 48 h of
culture by ELISA (B). * p ≤ 0.001.
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-
cells participated in the residual IL-12 secretory activity
(33 ± 7%) in neonates and (15 ± 8%) in adults. We cul-
tured the same numbers of neonate or adult sorted
CD14
+ cells in the presence of CpG for 48 h but very
little or no IL-12 was detected. Therefore, CD14
+ are
poor IL-12-producing cells in the absence of CD14
-
cells, suggesting an indirect activation mechanism
(Figure 4D). Flow cytometry analyses also revealed that
the proportion of CD14
+ cells among bulk MLN cells
was twice as high in neonates as in adults (Figure 4E).
Although we did not observe a direct correlation
between the proportion of CD14
+ cells in the MLN and
the IL-12 response to CpG-2006 (data not shown), this
quantitative difference may nevertheless contribute to
the higher responsiveness of neonatal MLN cells to
CpG-ODN.
Effects of TGFb1, IL-10 and type I IFN on the cytokine
response to CpG-ODN
Immune cells in the intestinal mucosa are conditioned
by many regulatory cytokines, including TGFb1a n d
IL-10, helping to avoid responses against commensal
flora and dietary antigens. Booth et al. observed the pre-
sence of regulatory B cells producing large amounts of
IL-10 in sheep Peyer’s patches and downregulating
TLR9-induced cytokine responses [28]. Therefore, we
tested the effect of rhTGFb1 and rovIL-10, during CpG-
ODN stimulation, on the IL-12 response of adult and
neonate MLN cells. TGFb1a n dI L - 1 0e a c hs t r o n g l y
inhibited IL-12 release in both neonates and adults (Fig-
ures 5A, B). At some concentrations, IL-12 secretions in
response to CpG from adult MLN cells were signifi-
cantly more sensitive than neonate MLN cells to these
regulatory cytokines. This may result from a higher
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Figure 4 Characterisation of IL-12-producing cells. Kinetics of the IL-12 response to CpG-2006 during the first 48 h was followed by ELISA.
Mean ± SEM IL-12 secretion (CpG-2006 - Ctl-ODN) is shown for each time point. Means ± SEM were calculated from three independent
experiments (three different neonates) giving similar results (A). Neonatal MLN cells were cultured in vitro with 1 μM Ctl-ODN (hatched bars) or
1 μM CpG-2006 (black bars) for 25 h, with brefeldin A added for the last 5 h. IL-12 intracellular staining was combined with labelling of CD11b,
CD14, MHC class II and CD205. Values reported are means ± SEM from three independent experiments (three different neonates) giving similar
results (B). Neonatal CD14
+ MLN cells were observed by transmission electron microscopy. The scale bar on the representative picture indicates
2 μm (C). Neonatal (n = 11, closed bars) and adult (n = 6, open bars) total MLN cells and sorted CD14
- cells and CD14
+ cells (n = 6 for neonates
and n = 5 for adults) were stimulated for 48 h with 1 μM CpG-2006 or 1 μM Ctl-ODN and ELISA was used to assay secreted IL-12 (CpG-2006 -
Ctl-ODN) (D). Mean ± SEM of CD14
+ cell proportions in 6- to 14-day-old neonatal (n = 27, closed bar) and adult (n = 13, open bar) total MLN
cells were assessed by single staining and flow cytometry (E).* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
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Figure 5 Effect of regulatory cytokines on the IL-12 response to CpG-2006. MLN cells from neonates (n = 3-5, closed bars) and adults (n =
5-7, open bars) were stimulated in vitro for 48 h with 1 μM of CpG-2006 or 1 μM of Ctl-ODN in the presence of each of various amounts of
rhTGFb1 (A), rovIL-10 (B) and rh type I IFN (E) and IL-12 secreted by MLN was assayed by ELISA (CpG-2006 - Ctl-ODN). The percentage of IL-12
secretion inhibition is shown for each dose of recombinant cytokine. MLN cells from neonates (closed circles) and adults (open squares) were
cultured in vitro for 48 h, with 1 μM CpG-2006 or 1 μM of Ctl-ODN. TGFb1 (C) and IL-10 (D) production was measured by ELISA and type I IFN
activity by bioassay (F). Plot values were calculated by subtracting the values for Ctl-ODN stimulated cells from those for CpG-2006 stimulated
cells. Medians are indicated for each group. * p ≤ 0.05; ** p ≤ 0.005.
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Page 7 of 12expression of the TGFb1a n dI L - 1 0r e c e p t o r so na d u l t
MLN cells compared to those of neonates and/or from
intracellular signalling differences. Possibly, regulatory T
cells, producing TGFb1a n dI L - 1 0 ,a r em o r en u m e r o u s
among adult MLN cells, explaining the lower overall
IL-12 secretion by total MLN cells. However, analysis of
FoxP3 mRNA expression by MLN cells was not consis-
tent with this possibility, as the expression level was
similar in neonatal and adult samples (data not shown).
Besides, no significant differences related to the secre-
tion of these two regulatory cytokines following CpG
stimulation were observed between neonates and adults
(Figures 5C, D). However, when TGFb1s e c r e t i o nw a s
detected in response to CpG-ODN, it may have affected
preferentially the IL-12 response of adult animals.
We next searched for differences that may affect the
signal provided by CD14
- cells to CD14
+ cells for IL-12
production. It has been reported that type I IFN either
stimulate or inhibit IL-12 production by myeloid cells
[29,30]. TLR9-triggering of plasmacytoid DC (pDC)
induces the secretion of large amounts of type I IFN
[31]. We investigated exactly how type I IFN influence
IL-12 secretion by CD14
+ MLN from neonates and
adults stimulated by CpG-2006. Interestingly, rhIFN
(IFNa hybrid) displayed suppressive properties on both
neonate and adult MLN cells (Figure 5E). We performed
a type I IFN bioassay on supernatants from neonate and
adult MLN cells after CpG-2006 stimulation to test
whether the lower IL-12 response in adults was asso-
ciated with higher levels of type I IFN, but no difference
in type I IFN concentrations were observed (Figure 5F).
Role of IL-15 in the IL-12 response of MLN cells to CpG-
ODN
A feedback loop of amplification has been described for
IL-15 in the IL-12 response to CpG-ODN involving
CD40/CD40L interaction [32]. As no ELISA is yet avail-
able for sheep IL-15, we studied its mRNA by quantita-
tive RT-PCR. qRT-PCR with MLN cells stimulated with
CpG showed that IL-15 mRNA was much more abun-
dant in neonatal cells than in their adult counterparts,
from 3 h to 20 h after stimulation with a kinetic of
expression similar to that of the IL-12/23p40 chain
(Figures 6A, 6B). To identify the main source of IL-15-
producing cells we analysed IL-15 mRNA in CD14
+ and
CD14
- cells from neonates activated with CpG-2006: IL-
15 mRNA was more abundant in CD14
+ cells (Figure
6C). To test that IL-15 can potentiate IL-12 secretion in
adult MLN cells, we added rhIL-15 at the same time as
CpG and the result was an IL-12 secretion that was
about three-fold higher than in the controls (Figure 6D).
We next analyzed the involvement of CD40 in the IL-12
production by adding an anti-CD40 mAb concomitantly
with IL-15 and CpG-2006 to adult MLN cell culture.
CD40 binding by the antibody reduced by 51 ± 19% the
IL-12 response relative to the isotype control mAb
(Figure 6E). This suggestst h a tC D 4 0b i n d i n gb yt h e
mAb limits its interaction with its ligand.
Discussion
Neonates are more sensitive to infections in particular
when exposed to poor sanitary conditions before their
immune system is fully developed. It is therefore impor-
tant to develop immunoprophylactic strategies dedicated
to neonates. With the discovery of TLRs and their
importance in the initiation of immune responses to
invading pathogens, a large set of new synthetic adju-
vants has been developed including CpG-ODN for use
against infectious disease and cancer [33-35]. In human
and mouse, the age-dependent response to TLR has
only been documented in cord blood cells and spleen
cells, respectively [36-38]. The size of small ruminants
facilitates investigation of these responses in different
organs including mucosal tissues and their draining
lymph nodes [19,28].
Here, we report that cells isolated from the MLN and
spleen in neonate lambs produced more IL-12 than
their equivalents in adults in response to CpG-2006.
This higher IL-12 production was responsible in large
part for the higher IFNg response in neonatal stimulated
MLN cells as revealed by in vitro IL-12 neutralisation
assay. We next examined the age until which neonate
cells produced more IL-12 than adults and found that
this stronger IL-12 response was restricted to about the
first two weeks of life: from age 20 days MLN from
lambs produced similar amounts of IL-12 as those from
adults. Interestingly, spleen cells from 20-day-old lambs
continued to produce more IL-12 in response to CpG-
ODN suggesting that a rapid and specific change in
TLR agonist responsiveness occurs in MLN. During this
period, the dietary regimen of lambs was similar with
reconstituted milk provided ad libitum.A sM L Nd r a i n
the intestinal tissue, we thought that the progressive
installation of the commensal flora might have influ-
enced TLR9 responsiveness. Indeed, Gram -ve bacteria
are important for lymphoid tissue development [25]. We
set up a protocol to control Gram -ve bacteria by feed-
ing lambs with reconstituted milk containing the anti-
biotic colistin. Although dramatically reducing Gram -ve
bacterial counts in the intestine of 20-day-old lambs,
this treatment did not significantly affect the capacity of
MLN cells to produce IL-12. We next investigated the
role of regulatory cytokines, including IL-10 and TGFb1
produced in large amounts in intestinal tissue. These
cytokines effectively suppressed IL-12 production by
MLN cells stimulated with CpG-2006. Although, in
response to CpG-2006 stimulation in vitro, they were
produced in similar amounts by MLN cells whatever the
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Page 8 of 12age of the animal and only detected for some animals.
Adult MLN cells activated with CpG-ODN presented a
slightly higher sensitivity to these cytokines at certain
concentrations. Therefore we cannot exclude that for
some animals it may participate to the lower IL-12
response of adults. Booth et al. [28] identified a CD5
-
CD21
+ B cell population in the ileal Peyer’s patches
(iPP) in adult sheep. These cells reduce the expression
of IFNg and IL-12 by iPP cells stimulated with CpG-
ODN by producing large amount of IL-10. However, in
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Figure 6 Role of IL-15 in the IL-12 response of MLN cells to CpG-2006. The kinetics of IL-15 (A) and IL-12/IL-23p40 (B) mRNA production in
response to CpG-2006 was determined by quantitative RT-PCR. Experiments were performed with MLN cells isolated from three neonates and
three adults. 20 h post-stimulation, MLN cells isolated from three different neonates were recovered and sorted into CD14
- and CD14
+ cell
subsets and IL-15 mRNA was assayed by quantitative RT-PCR in each subset (C). After normalisation with the reference gene (HPRT), the RT-PCR
data are reported as means ± SEM values of the ratio of CpG-2006 stimulated to Ctl-ODN stimulated cells (A, B, C). MLN cells, isolated from eight
adults, were stimulated with CpG-2006 for 48 h, with or without various amounts of rhIL-15; secreted IL-12 was measured by ELISA (D). The
mean ± SEM level of IL-12 secretion is shown for each dose of recombinant cytokine (CpG-2006 - Ctl-ODN). Adult MLN cells were stimulated
with CpG-2006 (or Ctl-ODN) and 200 IU/mL of IL-15 in the presence of anti-CD40 mAb or its isotype control and IL-12 was quantified by ELISA
48 h later (CpG-2006 - Ctl-ODN). Data are from one representative animal of five, all giving similar results (E). * p < 0.05; ** p < 0.005.
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Page 9 of 12agreement with our results the authors did not observe
any similar regulatory mechanism in the MLN [28]. To
continue, we needed to identify the cell population
responsible for IL-12 production. Intracellular IL-12
staining revealed that cells expressing CD14 and CD11b
were the main producers. These cells have a dendritic
morphology and resemble sheep bone marrow-derived
DC [26,27]. Possibly, these myeloid cells originate from
blood monocytes and differentiate into inflammatory
DC. These DC are known to produce abundant IL-12
and potently stimulate Th1 responses [39]. We observed
that the percentage of CD14
+ cells was higher in MLN
of neonates than of adults. This might contribute to the
higher IL-12 response of neonate MLN but we did not
observe a direct correlation between the percentage of
CD14
+ cells in MLN and the level of IL-12 produced
after CpG stimulation; consequently, we do not think
that this is the complete explanation. CD14
+ cells
respond poorly to direct CpG-2006 stimulation but
require the cooperation of other cells to release IL-12. It
has been reported that Mycobacterium bovis-induced IL-
12 secretion by bovine DC is enhanced by WC1
+ gδ T
cells [40]. Moreover, Hedges et al. observed that bovine
gδ T cells express different TLR including TLR9 and
respond directly to some pathogen-associated molecular
patterns like LPS and peptidoglycan, however in this
study the response of gδ T cells to CpG-ODN was not
investigated [41]. Therefore in our experimental model
gδ T cells may cooperate with CD14
+ cells for the IL-12
response to CpG-ODN. Another population, pDC have
been shown to cooperate with the IL-12 response of con-
ventional DC (cDC) to CpG-ODN [42]. Activated pDC
produce alpha IFN, cytokines that in our experimental
model inhibited the IL-12 response of MLN cells stimu-
lated with CpG-2006. After stimulation, we found only a
low level of type I IFN activity. This is probably because
CpG-2006 is a class B-ODN and this class induces type I
IFN much more weakly than do class A- and class C-
ODN. However, the level of type I IFN activity released
by neonates and adults being equivalent, this cannot
explain the difference in IL-12 production observed.
Kuwajima et al. showed that CpG-treated IL-15-deficient
mice produced little IL-12 [32]. They observed that CpG-
stimulated cDC were the main producers of both IL-15
and IL-12, but cDC did not produce IL-12 in the absence
of pDC. After CpG-2006 stimulation, we observed a
much stronger concurrent upregulation of IL-12p40 and
IL-15 mRNA in MLN cells from neonate than adult
sheep suggesting that in adults IL-15 availability may be
insufficient for the full activation. We therefore added
exogenous IL-15 to CpG-stimulated adult MLN cell and
observed an increase in IL-12 production of up to a
three-fold. When a CD40 mAb was added to the culture
medium, it reduced IL-12 production by half. This is
consistent with the findings of Kuwajima et al. [32] who
observed that IL-15-induced CD40 expression by cDC
and interaction between CD40 on cDC and CD40 ligand
on pDC led to IL-12 production by cDC. IL-15 therefore
plays a key role in the innate response to CpG and seems
to act via a feedback amplification loop. We recently
demonstrated that IL-15 is also an important molecule
for NK cells in neonates, another innate immune cell
population [3]. Indeed, NK cells from one week-old neo-
nate calves expanded in presence of IL-15, but not IL-2,
presented both a higher cytotoxicity than their equiva-
lents from older animals in direct lysis assay and a higher
IFNg response to IL-12 when associated with NKp46
receptor stimulation.
Here, we demonstrate the potential of CpG-ODN to
induce a preferential Th1-type cytokine and IL-15
response in neonate lambs. CpG oligonucleotides are
therefore potentially useful molecules for enhancing the
efficacy of vaccines against intracellular pathogens
affecting these animals.
Additional material
Additional file 1: List of primers used for qRT-PCR analysis. Table
showing complete list of primer pairs used for qRT-PCR analysis.
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